17734-21-3

Basic information

• Product Name: Benzenepentanamine
• Synonyms: Benzenepentanamine;(5-Aminopentyl)benzene;5-Phenylpentane-1-amine;5-Phenylpentylamine;Benzene-1-pentanamine
• CAS NO: 17734-21-3
• Molecular Formula: C₁₁H₁₇N
• Molecular Weight: 163.26
• Mol File: 17734-21-3.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 265.6°Cat760mmHg
• Flash Point: 114.2°C
• Appearance: /
• Density: 0.93g/cm³
• Vapor Pressure: 0.00906mmHg at 25°C
• Refractive Index: 1.518
• CAS DataBase Reference: Benzenepentanamine(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepentanamine(17734-21-3)
• EPA Substance Registry System: Benzenepentanamine(17734-21-3)

Safety Data

• Hazardous Substances Data: 17734-21-3(Hazardous Substances Data)

Usage

General Description

Benzenepentanamine, also known as N,N-dimethyl-1-phenylpentan-1-amine, is a chemical compound with the molecular formula C14H21N. It is an amine derivative of pentanamine and is commonly used as a reagent in organic synthesis. Benzenepentanamine is a colorless to pale yellow liquid with a strong odor, and it is soluble in organic solvents such as ethanol, ether, and chloroform. It is also used as a precursor in the production of pharmaceuticals, agrochemicals, and other organic compounds. Benzenepentanamine is considered to be a hazardous chemical and should be handled and stored with care to avoid any potential health risks.

InChI:InChI=1/C11H17N/c12-10-6-2-5-9-11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10,12H2

Upstream product

• 36603-28-8 5-phenylpentanitrile 
• 95109-78-7 4-(5-amino-pentyl)-aniline 
• 53429-14-4 2-(5-phenylpentyl)isoindoline-1,3-dione 
• 14469-83-1 (5-bromopentyl)benzene 
• 127611-46-5 ((Z)-5-Azido-pent-1-enyl)-benzene 
• 10521-91-2 5-phenylpentan-1-ol 
• 15733-63-8 5-chloropentylbenzene 
• 856348-73-7 6-(4-amino-phenyl)-hexanoic acid 
• 637-59-2 1-Bromo-3-phenylpropane 
• 7726-45-6 5-phenylvaleronitrile 
• 1823-14-9 5-phenyl-1-pentyne 
• 75803-20-2 methansulfonic acid 5-phenyl-pentyl ester 
• 118647-85-1 1-(5-azidopentyl)benzene 

Downstream Products

• 100794-46-5 3-chloro-propionic acid-(5-phenyl-pentylamide) 
• 62101-03-5 trimethyl-(5-phenyl-pentyl)-ammonium; iodide 
• 109848-71-7 DL-N-Pantoyl-5-phenyl-pentylamin 
• 143769-68-0 2-Phenyl-ethanesulfonic acid (5-phenyl-pentyl)-amide 
• 98510-42-0 2-Amino-5-nitroso-6-(5-phenyl-pentylamino)-3H-pyrimidin-4-one 
• 82173-88-4 C₂₂H₃₃N₃O₄S₂ 
• 263139-50-0 (+/-)-3-(4-methoxyphenyl)-1-(5-phenylpentyl)pyrrolidine 
• 872215-00-4 C₅₉H₇₉N₃O₁₆ 
• 143769-86-2 6-(5-Phenyl-pentyl)-5,6,8,9-tetrahydro-7-thia-6-aza-benzocycloheptene 7,7-dioxide 

Relevant articles and documents

Heterocyclization involving benzylic C(sp3)-H functionalization enabled by visible light photoredox catalysis

A general and efficient method for heterocyclization involving benzylic C(sp3)-H functionalization enabled by visible light photoredox catalysis to access a wide range of structurally diverse oxygen as well as nitrogen heterocycles up to a gram scale is reported. The potential application of this new methodology is demonstrated by the total synthesis of (-)-codonopsinine and (+)-centrolobine. Herein it is proposed that selectfluor, unlike a fluorinating reagent, acts as an oxidative quencher and a hydrogen radical acceptor.

meta-Selective C?H Borylation of Benzylamine-, Phenethylamine-, and Phenylpropylamine-Derived Amides Enabled by a Single Anionic Ligand

Selective functionalization at the meta position of arenes remains a significant challenge. In this work, we demonstrate that a single anionic bipyridine ligand bearing a remote sulfonate group enables selective iridium-catalyzed borylation of a range of common amine-containing aromatic molecules at the arene meta position. We propose that this selectivity is the result of a key hydrogen bonding interaction between the substrate and catalyst. The scope of this meta-selective borylation is demonstrated on amides derived from benzylamines, phenethylamines and phenylpropylamines; amine-containing building blocks of great utility in many applications.

ACID CERAMIDASE INHIBITORS AND THEIR USE AS MEDICAMENTS

The present invention concerns, in a first aspect, compounds of Formula I as defined herein, pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The present invention also relates to compounds of Formula I